| Professional Services Industry | Industrials Sector | Mr. Wu Mingjian CEO | XSHE Exchange | CNE1000020H3 ISIN |
| CN Country | 3,472 Employees | 28 May 2025 Last Dividend | 8 Jun 2016 Last Split | - IPO Date |
Maccura Biotechnology Co.Ltd is an innovator and manufacturer in the In Vitro Diagnostics (IVD) industry, operating on a global scale. Since its inception in 1994, the company has been dedicated to the research, development, manufacturing, and sale of IVD products, serving both Chinese and international markets. Based in Chengdu, China, Maccura Biotechnology maintains a steadfast commitment to advancing medical diagnostics through its comprehensive product offerings and services, contributing to the global healthcare industry's ability to combat various diseases, including the recent COVID-19 pandemic.
Maccura Biotechnology Co.Ltd provides a wide range of IVD products and related services, categorized as follows: